SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-20-003974
Filing Date
2020-02-14
Accepted
2020-02-14 16:43:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D sc13d0220a1tesi_inmune.htm SC 13D/A 66131
  Complete submission text file 0001213900-20-003974.txt   67401
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Subject) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90859 | Film No.: 20621214
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 476 MASSACHUSETTS AVE, UNIT 2 BOSTON MA 02118
Business Address
Tesi Raymond Joseph (Filed by) CIK: 0001767280 (see all company filings)

Type: SC 13D/A